Scholar Rock Holding ( NASDAQ: SRRK ) on Monday said it has commenced an underwritten public offering for $275 million of shares of its common stock and pre-funded warrants. Scholar Rock intends to use the net proceeds to support commercialization of apitegromab, to advance.
Back to Health Page
